The Indian government has prohibited the manufacturing and export of a dangerous combination of opium drugs, Tapentadol, Carisoprodol. The development has come days after media reports claimed these were being misused in certain West African nations.
The Union Health and Family Welfare Ministry halted all operations at the premises of Mumbai-based Aveo Pharmaceuticals after an audit by a joint team from the Central Drugs Standard Control Organisation (CDSCO) and the state regulatory authority, PTI reported on Sunday.
Amid reports of misuse of unapproved combination drugs containing Tapentadol and Carisoprodol in West African nations, the Centre has banned their production and export in India.
Maharashtra Food and Drug Administration has issued a Stop Production Order to “M/s. Aveo Pharmaceuticals” on February 22 for the production and export of the combination drug.
“Following the audit, the investigation team seized all raw materials, in-process materials, and finished products. Approximately 1.3 crore tablets/capsules and 26 batches of APIs (Active Pharmaceutical Ingredients) of Tapentadol and Carisoprodol were detained to prevent further distribution of these potentially dangerous drugs,” ANI quoted health ministry’s statement.
These drugs are made from natural substances found in the opium poppy plant. Here are the key side-effects of these ‘addictive’ drugs.
Tapentadol is a strong opioid, which is a class of drugs generally made from the opium poppy plant. The category of these drugs is used as painkillers as they block pain signals by binding to opioid receptors on nerve cells, according to the National Cancer Institute.
Carisoprodol is a muscle relaxant. According to an official’ Drug Safety’ update by the United Kingdom, the drug carries the risk of abuse, addiction, intoxication, and psychomotor impairment. The drug is banned in the UK.
Individual sales of Tapentadol and Carisoprodol are not banned in India. However, the sale as combination drugs is prohibited by the Central Drugs Standard Control Organization (CDSCO) in India.
“Tapentadol and Carisoprodol are individually approved by CDSCO in India. Tapentadol is approved in 50, 75, and 100 mg tablet forms and 100, 150, and 200 mg extended-release tablets. However, the combination of Tapentadol and Carisoprodol is not approved in India,” read a Union Health and Family Welfare Ministry’s release.
An opioid crisis was also flagged during the US presidential campaign by Donald Trump, who charged fentanyl as a key drug being exported by China and linked it to his broader narrative on border security, trade, and the opioid crisis in the United States. Trump charged that China was a primary source of fentanyl and other chemicals fueling America’s drug epidemic.
Catch all the Business News , Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.